Last modified by Wilton Risenhoover on 2022/07/01 19:35
From version < 5.1 >
edited by Asif Farooqui
on 2021/03/29 13:42
To version < 5.2 >
edited by Asif Farooqui
on 2021/03/31 14:38
< >
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -104,8 +104,9 @@
104 104  * Net Sales at Rs 857.20 crore in December 2020 up 10.1% from Rs. 778.59 crore in December 2019.
105 105  * Quarterly Net Profit at Rs. 156.51 crore in December 2020 up 123.67% from Rs. 661.16 crore in December 2019.
106 106  * EBITDA stands at Rs. 219.53 crore in December 2020 up 55.82% from Rs. 140.89 crore in December 2019.
107 -* GlaxoSmithKline EPS has increased to Rs. 9.24 in December 2020 from Rs. 39.03 in December 2019.
107 +* GlaxoSmithKline EPS has increased to Rs. 9.24 in December 2020 from Rs. - 39.03 in December 2019.
108 108  
109 +{{putFootnotes/}}
109 109  
110 110  = References =
111 111  
This site is funded and maintained by Fintel.io